Anti-Aging Study
Oklahoma Medical Research Foundation scientists are studying healthy aging.
Oklahoma Medical Research Foundation scientist Benjamin Miller, Ph.D., leads a team of researchers working to improve medical and treatment practices by developing a better understanding of the biological process of aging.
Why study aging?
As we grow older, we are more likely to develop Type 2 diabetes, cardiovascular disease, Alzheimer’s and many other conditions that are difficult and expensive to treat. Scientists believe that slowing aging may delay or prevent chronic diseases rather than treating these diseases one at a time.
Our research
With the help of healthy individuals 40-75 years old, Dr. Miller’s team studied whether Metformin, an FDA-approved drug currently used to treat Type 2 diabetes, helped slow aging and delay the onset of chronic diseases.
Who can participate?
This study is no longer taking participants.
Questions?
Gina Hebert
Oklahoma Shared Clinical and Translational Resources
405-271-3480
osctr@ouhsc.edu
The University of Oklahoma is an equal opportunity institution. IRB #10699. IRB approval date: 09/29/2023.
